Literature DB >> 21912960

The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China?

Rong Liu1, Hui-Fen Dong, Ming-Sen Jiang.   

Abstract

Artesuante (AS) is a good chemoprophylactic drug for preventing against schistosome infection, but Hua et al. recently reported that the sensitivity of AS against Schistosoma japonicum decreased after 10 years of use in China. There are at least three problems, to our knowledge, making the finding suspicious or inconclusive in that report. In consideration of it as the first report about the emergence of potential artemisinin derivative-resistant S. japonicum to date and the possible severe influences of the emergence of AS-resistant S. japonicum on the future choice of chemoprophylactic drugs for preventing against S. japonicum infections in China, we write this comment and call for some more rigorous and convincing trials to confirm this finding further.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912960     DOI: 10.1007/s00436-011-2641-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  3 in total

Review 1.  Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins.

Authors:  Shu-Hua Xiao
Journal:  Acta Trop       Date:  2005-08-19       Impact factor: 3.112

2.  The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China.

Authors:  Hai-Yong Hua; You-Sheng Liang; Yan Zhang; Ji-Fu Wei; Hong-Xiong Guo
Journal:  Parasitol Res       Date:  2010-06-15       Impact factor: 2.289

3.  Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria.

Authors:  P C Inyang-Etoh; G C Ejezie; M F Useh; E C Inyang-Etoh
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-10-05       Impact factor: 2.184

  3 in total
  6 in total

Review 1.  A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.

Authors:  Xu-Guang Zhang; Gui-Xin Li; Shu-Shun Zhao; Fu-Liang Xu; Yun-Hai Wang; Wei Wang
Journal:  Parasitol Res       Date:  2014-03-08       Impact factor: 2.289

2.  Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.

Authors:  Rong Liu; Hui-Fen Dong; Ming-Sen Jiang
Journal:  Parasitol Res       Date:  2011-10-27       Impact factor: 2.289

3.  Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection.

Authors:  Hong-Jun Li; Fu-Liang Xu; Yun-Hai Wang; Zheng-Jun Yi; Wei Wang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

4.  Stem cell therapy for the treatment of parasitic infections: is it far away?

Authors:  Yan Zhang; Jing-Yi Mi; Yong-Jun Rui; Yong-Liang Xu; Wei Wang
Journal:  Parasitol Res       Date:  2013-11-26       Impact factor: 2.289

Review 5.  Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis.

Authors:  Rong Liu; Hui-Fen Dong; Yi Guo; Qin-Ping Zhao; Ming-Sen Jiang
Journal:  Parasit Vectors       Date:  2011-10-17       Impact factor: 3.876

Review 6.  New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China.

Authors:  Yi-Xin Liu; Wei Wu; Yue-Jin Liang; Zu-Liang Jie; Hui Wang; Wei Wang; Yi-Xin Huang
Journal:  Molecules       Date:  2014-09-19       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.